Adial Pharmaceuticals, Inc.
USD2.32
-0.04 (-1.69%)
CEO
Cary John Claiborne
IPO Date
2018-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.27
Prev. Close
$2.36
Day Low
$2.25
Day High
$2.33
52W Low
$1.31
52W High
$19.00
Market Cap
$0.00B
Volume
0.02M
| 9,185 |
| $1.64 |
| 9 Apr 2026 | Schuyler Kevin | director | A-Award | Acquired | 9,185 | $0.00 |
| 9 Apr 2026 | Shah Vinay | Chief Financial Officer | A-Award | Acquired | 17,325 | $0.00 |
| 9 Apr 2026 | Gilliland Robertson H. | director | A-Award | Acquired | 9,185 | $0.00 |
| 9 Apr 2026 | Claiborne Cary J | director, officer: Chief Executive Officer | A-Award | Acquired | 37,985 | $0.00 |
| 2 Jun 2025 | Gilliland Robertson H. | director | A-Award | Acquired | 28,000 | $0.69 |
| 2 Jun 2025 | Newman James W. Jr. | director | A-Award | Acquired | 28,000 | $0.69 |
| 2 Jun 2025 | Shah Vinay | Chief Financial Officer | A-Award | Acquired | 9,000 | $0.69 |
| 2 Jun 2025 | Schuyler Kevin | director | A-Award | Acquired | 28,000 | $0.69 |